| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Orthovita has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Orthovita, Inc. | 41 |
$65 |
| 28-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Health Serv & Equipment Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards. | 65 |
$20 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | ORTHOVITA INC (VITA=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | ORTHOVITA INC (VITA=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: ORTHOVITA -- VITA | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ALTUQ , CYTK , IMMU , VITA , TRBN , VICL -- DRUGS | 3 |
$4 |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| VITA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | ORTHOVITA INC (VITA=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for VITA | 13 |
$25 |
1.48% Nasdaq 
Research Reports
